Picture BIO Deutschland Corona Special Germany 2020 650x80px
Organisation › Details

KineMed Inc.

KineMed is a commercial-stage company focused on applying its proprietary biomarker platform technology to drug development, prescription and non-prescription medical diagnostics and the pairing of drugs with diagnostic biomarker tests. KineMed's diagnostic biomarker tests directly measure the biological processes that cause disease by revealing the flux, or rate of production and destruction, over a period of time, of the key molecules involved in these biological processes. KineMed believes that measuring molecular fluxes can provide interpretable information that may be predictive for clinically meaningful endpoints for a particular patient and are designed to reveal personalized information for a patient that can guide healthcare decisions. As a result, KineMed believes KineMed's biomarkers have the potential to have a transformative effect on healthcare by providing information that can be used to make drug development more efficient, and guide healthcare decisions by physicians and wellness decisions by consumers. Building on a legacy of collaborative relationships and experience performing biomarker tests in human disease research and drug development settings, KineMed is currently focused on commercializing biomarker tests in six areas: muscle biology, fibrotic diseases, neurodegenerative diseases, cardiometabolic diseases, skincare and cancer. KineMed's muscle biology program represents its most advanced initiative that focuses its proprietary technology on a long-standing need in medicine and wellness management. *


Period Start 2005-03-01 existent
Products Industry drug development services
  Industry 2 mass spectrometry services (MS services)
Persons Person Fineman, David (KineMed 200708 President + CEO)
  Person 2 Kiron, Ravi (KineMed 201401 CBO)
Region Region Emeryville, CA
  Country United States (USA)
  Street 5980 Horton Street
Suite 470
  City 94608 Emeryville, CA
  Tel +1-510-655-6525
    Address record changed: 2018-07-24
Basic data Employees n. a.
    * Document for �About Section�: KineMed Inc.. (1/13/14). "Press Release: KineMed Announces Agreement with EMD Serono to Identify Protein and Lipid Biomarkers for Multiple Sclerosis". Emeryville, CA.
Record changed: 2018-10-31


Picture Fairtec GmbH Worldwide Event Solutions 650x65px

More documents for KineMed Inc.

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture [iito] Made Without Love 650x80px

» top